Rare diseases
Investigational molecules
Locations
Poligono Industrial Els Vinyets Els Fogars Sector II, 08777, Spain
Bcn Peptides S.A. is engaged in clinical research focused on non-proliferative diabetic retinopathy, with attention to microaneurysm burden and retinal disease progression in patients with moderate to severe forms of the condition.
The sponsor’s work in this area reflects a therapeutic interest in topical ophthalmic treatments for preserving retinal health.
Bcn Peptides S.A. runs clinical trials in conditions such as Diabetic retinopathy, among others.
Clinical trials run by this sponsor – those enrolling participants first.
SpainIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
